Content by The Scientist

Fujirebio's Lumipulse® G pTau217/β-Amyloid 1-42 Plasma Ratio test has the potential to shorten the Alzheimer's disease diagnostic journey and enable earlier intervention through its accessibility and high diagnostic performance.

Biosensing plays a fundamental role in the latest technology that sheds light on how G protein-coupled receptors are activated by synthetic cannabinoid receptor agonists.

Scientists optimize cell culture-based workflows with a wide range of methods for monitoring transfection outcomes.

Explore how BioTech360 makes “good data” accessible, reshaping what’s possible in life sciences research and development.

Ramona’s Vireo platform is recognized in the 2025 Top Innovations Startup category for its unique multi-camera microscope array-based approach to illuminating live-cell research.

Recognized in the Healthcare category of the 2025 Top Innovations contest, Haystack MRD® enables minimal residual disease monitoring via circulating tumor DNA.

Mark Wetzel from Aldevron highlights how rapid, tailored gene-editing treatments could transform care for rare diseases.

A company developing HiFi sequencing technology is one of the 2025 Top Innovations contest winners in the Lab Research category.

Recognized as a 2025 Top Innovations pick in the Biotechnology category, AVITI24 from Element Biosciences enables true multiomic data generation from a single sample, in a single run.

A better understanding of immune checkpoint signaling can help improve future checkpoint inhibitor therapeutic approaches. 

Recent discoveries in cancer immunotherapy reveal new factors that may affect patients’ treatment response and help researchers improve these outcomes.

Winning a spot in the 2025 Top Innovations contest’s Lab Research Tools category, the CUTANA™ meCUT&RUN kit harnesses engineered proteins to capture DNA methylation sites at scale.

Ultima Genomics’ UG 100 Solaris™ is among the 2025 Top Innovations contest winners in the Biotechnology category.

Fred Grossman from Coya Therapeutics speaks about a novel immunomodulatory therapy for slowing amyotrophic lateral sclerosis (ALS) by restoring immune balance and protecting neurons from inflammation.

Diana Dickson from Fujirebio Diagnostics discusses the company’s blood-based diagnostic test, which promises earlier and easier detection of Alzheimer’s disease by measuring key biomarkers.